Global Distribution Patterns of Carbapenemase-Encoding Bacteria in a New Light: Clues on a Role for Ethnicity
- PMID: 34268132
- PMCID: PMC8276097
- DOI: 10.3389/fcimb.2021.659753
Global Distribution Patterns of Carbapenemase-Encoding Bacteria in a New Light: Clues on a Role for Ethnicity
Abstract
Antibiotic resistance represents a major global concern. The rapid spread of opportunistically pathogenic carbapenemase-encoding bacteria (CEB) requires clinicians, researchers, and policy-makers to swiftly find solutions to reduce transmission rates and the associated health burden. Epidemiological data is key to planning control measures. Our study aims to contribute by providing an analysis of 397 unique CEB isolates detected in a tertiary hospital in Germany. We propose new findings on demographic variables to support preventive sanitary precautions in routine clinical practice. Data on detected CEB was combined with patient's demographic and clinical information for each isolate. Multiple regression techniques were applied to estimate the predictive quality of observed differences. Our findings confirm the role of age and gender in CEB colonization patterns and indicate a role for ethnicity and domicile. Also, carbapenemase-encoding A. baumannii was most frequently introduced to the hospital, while the risk of colonization with VIM-encoding P. aeruginosa rose with the length of hospital stay. P. aeruginosa remains an important complication of prolonged hospital stays. The strong link to hospital-wastewater may have implications for hospital-built environments. A. baumannii can be efficiently controlled from spreading at hospital admission. OXA-encoding CEB being harder to detect in routine screening, targeted preventive measures, such as culture media selective for carbapenem-resistant bacteria, would be opportune for patients from selected regions. The CEB differences linked to ethnicity found in our study may further be supporting the tailoring of diagnostic approaches, as well as health policies upon confirmation by other studies and a better understanding of their global distribution.
Keywords: antibiotic resistance screening; carbapenem-resistant Acinetobacter baumannii; carbapenem-resistant Enterobacterales; carbapenem-resistant Enterobacteriaceae; carbapenem-resistant Gram negative bacteria; carbapenem-resistant Pseudomonas aeruginosa; carbapenemases.
Copyright © 2021 Neidhöfer, Buechler, Neidhöfer, Bierbaum, Hannet, Hoerauf and Parčina.
Conflict of interest statement
IH was employed by the company H.I.M.A. Consulting. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Epidemiological, Physiological, and Molecular Characteristics of a Brazilian Collection of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.Microb Drug Resist. 2017 Oct;23(7):852-863. doi: 10.1089/mdr.2016.0219. Epub 2017 Feb 24. Microb Drug Resist. 2017. PMID: 28437232
-
Carbapenemase Detection among Carbapenem-Resistant Glucose-Nonfermenting Gram-Negative Bacilli.J Clin Microbiol. 2017 Sep;55(9):2858-2864. doi: 10.1128/JCM.00775-17. Epub 2017 Jul 12. J Clin Microbiol. 2017. PMID: 28701421 Free PMC article.
-
Carbapenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii at Mulago Hospital in Kampala, Uganda (2007-2009).Springerplus. 2016 Aug 9;5(1):1308. doi: 10.1186/s40064-016-2986-7. eCollection 2016. Springerplus. 2016. PMID: 27547682 Free PMC article.
-
Carbapenem resistance in Pseudomonas aeruginosa and Acinetobacter baumannii in the nosocomial setting in Latin America.Crit Rev Microbiol. 2016;42(2):276-92. doi: 10.3109/1040841X.2014.940494. Epub 2014 Aug 27. Crit Rev Microbiol. 2016. PMID: 25159043 Review.
-
Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.Clin Microbiol Infect. 2006 Sep;12(9):826-36. doi: 10.1111/j.1469-0691.2006.01456.x. Clin Microbiol Infect. 2006. PMID: 16882287 Review.
Cited by
-
Trends in Antibiotic-Resistant Bacteria Isolated from Screening Clinical Samples in a Tertiary Care Hospital over the 2018-2022 Period.Antibiotics (Basel). 2023 Aug 14;12(8):1314. doi: 10.3390/antibiotics12081314. Antibiotics (Basel). 2023. PMID: 37627734 Free PMC article.
-
ESKAPEE Pathogen Biofilm Control on Surfaces with Probiotic Lactobacillaceae and Bacillus species.Antibiotics (Basel). 2023 May 8;12(5):871. doi: 10.3390/antibiotics12050871. Antibiotics (Basel). 2023. PMID: 37237774 Free PMC article. Review.
-
Hospital sanitary facilities on wards with high antibiotic exposure play an important role in maintaining a reservoir of resistant pathogens, even over many years.Antimicrob Resist Infect Control. 2023 Apr 15;12(1):33. doi: 10.1186/s13756-023-01236-w. Antimicrob Resist Infect Control. 2023. PMID: 37061726 Free PMC article.
-
Examining Different Analysis Protocols Targeting Hospital Sanitary Facility Microbiomes.Microorganisms. 2023 Jan 11;11(1):185. doi: 10.3390/microorganisms11010185. Microorganisms. 2023. PMID: 36677477 Free PMC article.
-
Multiplex PCR Detection of Common Carbapenemase Genes and Identification of Clinically Relevant Escherichia coli and Klebsiella pneumoniae Complex.Antibiotics (Basel). 2022 Dec 31;12(1):76. doi: 10.3390/antibiotics12010076. Antibiotics (Basel). 2022. PMID: 36671277 Free PMC article.
References
-
- Albiger B., Glasner C., Struelens M. J., Grundmann H., Monnet D. L., the European Sur-vey of Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) working group (2015). Carbapenemase-Producing Enterobacteriaceae in Europe: Assessment by National Experts From 38 Countries, May 2015. Eurosurveillance 20 (45), 1–18. 10.2807/1560-7917.ES.2015.20.45.30062 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
